Regeneron Pharmaceuticals (REGN) Gross Profit Growth (3y) (2012 - 2026)
Regeneron Pharmaceuticals (REGN) Gross Profit Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.60 Bn | 466.80 Bn | 1.35 Bn | 54.36% |
| 5 | Vertex Pharmaceuticals | 121.71 Bn | 114.46 Bn | 2.59 Bn | 7.16% |
| 6 | Regeneron Pharmaceuticals | 69.83 Bn | 61.07 Bn | 3.31 Bn | 3.86% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 79.18% |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn | 51.16% |
| 10 | Revolution Medicines | 37.31 Bn | 37.31 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.86% |
| Dec 31, 2025 | 184.58% |
| Sep 30, 2025 | 7.97% |
| Jun 30, 2025 | 7.88% |
| Mar 31, 2025 | 171.40% |
| Dec 31, 2024 | -13.93% |
| Sep 30, 2024 | 2.47% |
| Jun 30, 2024 | -12.63% |
| Mar 31, 2024 | 7.96% |
| Dec 31, 2023 | 10.01% |
| Sep 30, 2023 | 13.42% |
| Jun 30, 2023 | 16.78% |
| Mar 31, 2023 | 19.08% |
| Dec 31, 2022 | -28.41% |
| Sep 30, 2022 | 16.99% |
| Jun 30, 2022 | 20.21% |
| Mar 31, 2022 | -28.55% |
| Dec 31, 2021 | 42.17% |
| Sep 30, 2021 | 26.60% |
| Jun 30, 2021 | 46.91% |